Physician profile
James M Boler
NPI 1245221928
$1,697.08
in general payments reported to CMS, 2019-2025
7 companies · $1,107 in 2025
The $1,107 reported for 2025 was more than what 75% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2023: $14.71 · 2024: $365 · 2025: $1,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $751 · Food and Beverage: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $750.56 |
| Food and Beverage | $736.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prodigy Surgical Distribution, INC. | $812.06 | 2025 | |
| Axogen | $304.52 | 2019-2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Arthrex, INC. | $268.20 | 2025 | |
| Stryker Corporation | $175.36 | 2019-2025 | Axsos, Conextions Tr Tendon Repair System-Implant Mechanism |
| Depuy Synthes Sales INC. | $86.55 | 2019-2024 | Va-Lcp, Tfn-Advance |
| Skeletal Dynamics INC | $35.68 | 2024 | Ijs, Geminus, Implate |
| International Rehabilitative Sciences, INC | $14.71 | 2023 | Rs 4i Plus Sequential Stimulator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Boler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.